
The pharmaceutical industry is well-positioned for significant expansion, driven by robust demand amid the growing prevalence of chronic diseases and an aging population, continued innovations and discoveries in drug discovery and development, and technological advances such as AI, big data analytics, and precision medicine.
Amid this backdrop, investors could consider investing in quality pharmaceutical stocks Zoetis Inc. (ZTS), Viatris Inc. (VTRS), and Bristol-Myers Squibb Company (BMY) with significant potential.